A review of the effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors on lean body mass in humans
That can stop you from reaching for seconds before you really need them
Never dispose of medication in household waste or down drains, as this may contaminate water supplies
Sin embargo, para millones de personas que ya estn sopesando la posibilidad de empezar a tomar un frmaco GLP-1 para la diabetes, la obesidad u otra indicacin aprobada, es un factor ms que vale la pena tener en cuenta
*The anti-obesity drugs' estimated percentile ranking of weight loss of 10% in participants who took weight-loss medications for more than a year is Phentermine-Topiramate, 54%
10.1038/s41467-023-44067-4 [DOI] [PMC free article] [PubMed] [Google Scholar] Kanmani P., Villena J., Lim S.-K., Song E.-J., Nam Y.-D., Kim H